IP Library Assignment 044182/0962
Patent Assignment
Reel/Frame 044182/0962

Assignment of Assignor's Interest

Recorded: 2017-11-20 Pages: 2
Assignor
NESTOR, JOHN J.
Executed: 2017-11-17
Assignee
SPITFIRE PHARMA, INC.
400 OYSTER POINT BLVD., SUITE 202, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property (1)
Improved Peptide Pharmaceuticals for Insulin Resistance
Patent: 9,856,306 →
Application: 15/314,466 →
Publication: US 2017/0096468
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 20, 2017
From: NESTOR, JOHN J.
To: SPITFIRE PHARMA, INC.
Reel/Frame 044183/0041 →
Assignment of Assignor's Interest Jul 20, 2019
From: SPITFIRE PHARMA INC.
To: MEDERIS DIABETES INC.
Reel/Frame 049809/0931 →
Affidavit of Address Change Feb 19, 2025
From: MEDERIS DIABETES, LLC
To: MEDERIS DIABETES LLC
Reel/Frame 070266/0875 →
Security Interest May 14, 2025
From: ALTIMMUNE, INC.; SPITFIRE PHARMA, LLC
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 071108/0692 →